Imlay Innovation Fund

Pediatric Technology Center (PTC) Request for Proposals

Imlay Innovation Fund

Program Purpose: The Imlay Innovation Fund is intended solely to support collaborative activities and pediatric innovation and discovery efforts between Georgia Tech and Children’s, focusing on practical steps that will lead to clinical impact as well as potential commercial opportunities.


Proposals should focus on solving a problem related to the theme of Quality / Patient Safety.  Examples may include, but are not limited to:

  • Central Line-Associated Blood Stream Infections (CLABSI)
  • Catheter-Associated Urinary Tract Infections (CAUTI)
  • IV Infiltrate Prevention
  • Pressure Ulcer Prevention
  • Medication Error Prevention

Two types of projects are eligible for funding:

  1. Imlay Quick Wins: Quick Wins (QW) allows Children’s clinicians and clinical administrative leaders to bring problems that impact care delivery to the attention of scientists and engineers at Georgia Tech to help develop innovative solutions. Successful projects have ranged from pediatric specific surgical device development in partnership with a surgeon and biomedical engineer to improvement of workflow in a busy outpatient clinic in partnership with physicians, clinical administrative leadership, architectural researchers, and industrial engineers.                                                                                                                                                                                                                                                    Quick Wins supports projects that can be accomplished in 12-18 months and can be quickly translated into practice. It is possible, but not guaranteed, that a Quick Wins award could help to position an investigator for a successful Innovation Investment application (described below) within the 2 years following the QW award. Quick Wins awards will be funded up to $125K.

  2. Innovation Investment: Innovation Investment is intended to help bridge the funding gap that often blocks the next phase of implementation or commercialization after initial proof of concept. Innovation Investment awards should allow investigators to collect much-needed data, complete further proof-of-concept studies, or to produce prototypes for testing in order to effectively compete for extramural or investment funding.                                                                                                                                                                                                                  Innovation Investment projects will typically be funded for a one-year period. Applications for multi-year awards will be accepted only with prior approval, and can receive a total of no more than $250K.An important part of the proposal is a potential for commercialization and/or implementation, as well as potential to positively impact child health.


To apply

  1. All applicants should submit a pre-proposal no later than Friday, March 17.
  2. The pre-proposal is limited to 2 pages and must follow the format of Exhibit 2. The pre-proposal should be emailed to
  3. As mentioned in the purpose statement, each project must be a collaborative effort involving both Children’s clinicians and Georgia Tech faculty. For assistance in identifying suitable collaborators for your project, contact one of the following advisors:  


    Kris Rogers, RN, Children’s VP Research and Academic Administration: or 404-785-1215
    Leanne West, MS, Chief Engineer, Pediatric Technologies: or 404-431-9894
    M.G. Finn, PhD, Chief Scientific Officer: or 404-385-0906


  4. Please note that even if a collaborative, cross-institutional team has already been formed, applicants are encouraged to contact one of the above advisors to discuss the project prior to submission.

Pre-proposal review

Pre-proposal review will be conducted by a team of subject matter experts to identify the proposals with the highest likelihood of being funded.  PIs whose proposals are selected will be notified by April 1 and invited to submit a full proposal. PIs whose pre-proposals are not selected will receive feedback from the initial review.

Full proposal and oral pitch            

  1. Specific quarterly milestones must be defined in the full (five-page) application. Applicants must also give a brief oral presentation to the Leadership Team/SME Panel.
  2. Review panels will follow scoring guidelines based on those used by National Institutes of Health, modified for the more practical and focused nature of The Imlay Innovation Fund.
  3. The Leadership Team will make final funding decisions regarding each project.

Project selection

Applicants will be notified of the evaluation of their proposal status by June 1.

Estimated Start Date

Proposals selected for funding can expect to begin work in July, provided that all compliance requirements, including IRB approvals, where applicable, have been met.


All applications must involve two or more investigators, at least one from Georgia Tech faculty and at least one of whom:

  • has a primary faculty appointment in the Emory Department of Pediatrics OR
  • is on the professional staff at Children's Healthcare of Atlanta. This includes Emory faculty outside of the Department of Pediatrics who are on the Children’s medical staff and all non-faculty clinicians who are on the Children’s medical staff.


  • The principal investigator(s) must submit a mid-term progress report.
  • Proposal budgets must include administrative support and data support as needed.


Jen King, Project Manager, Research and Academic Administration or 404-785-1581